CTMX EPS Estimates
CytomX Therapeutics, Inc.
$2.39
+$0.15(+6.95%)
45
Overall
45
Value
45
Tech
47
Quality
Market Cap
$485.92M
Volume
753.36K
52W Range
$2.43 - $8.21
Target Price
$12.25
CTMX EPS estimates: the consensus estimate for CytomX Therapeutics, Inc.'s current fiscal year is -$0.40 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CTMX EPS Estimates
- EPS estimate, current quarter
- $-0.09
- EPS estimate, next quarter
- $-0.10
- EPS estimate, current year
- $-0.40
- EPS estimate, next year
- $-0.52
- EPS growth, 3-year
- +53.69%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.15 |
| 2024 | $0.38 |
| 2023 | $-0.01 |
| 2022 | $-1.51 |
| 2021 | $-1.30 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTMX | $2.39 | +7.0% | 753.36K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get CytomX Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW